← FDA DRUG APPROVALS

FDA ANDA · ANDA204749

CLINDAMYCIN PHOSPHATE

Sponsor: RISING

APPLICATION
ANDA204749
TYPE
ANDA
ORIGINAL APPROVAL
2017-10-10
LATEST ACTION
2025-04-07
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CLINDAMYCIN PHOSPHATEDiscontinued
CLINDAMYCIN PHOSPHATE EQ 150MG BASE/ML · INJECTABLE · INJECTION

Approval history

2025-04-07Labeling · Supplement 4 · standardAP
2025-04-07Labeling · Supplement 2 · standardAP
2025-04-07Labeling · Supplement 5 · standardAP
2025-04-07Labeling · Supplement 1 · standardAP
2017-10-10UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →